Simultaneous Publications at EuroPCR 2023!


EuroIntervention has released multiple articles in conjunction with EuroPCR 2023. Along with 3 major simultaneous publications, we have 3 Late Breaking Trials and 2 abstracts.

 
Tuesday 16 May
  • Stepwise provisional versus systematic culotte for stenting of true coronary bifurcation lesions: five-year follow-up of the multicentre randomised EBC TWO Trial from Sandeep Arunothayaraj et al.
Wednesday 17 May
  • A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3G): one-year results of the BIOMAG-1 first-in-human study from Michael Haude et al.
Thursday 18 May
  • Transcatheter aortic valve implantation with the Evolut platform for bicuspid aortic valve stenosis: the international, multicentre, prospective BIVOLUTX registry from Didier Tchetche et al.
Friday 19 May
  • Venoarterial extracorporeal membrane oxygenation or standard care in patients with cardiogenic shock complicating acute myocardial infarction: the multicentre, randomised EURO SHOCK trial from Amerjeet Singh Banning et al.

  • Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR) from Susheel K. Kodali et al.
Receive our newsletter

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved